Iman Osman

Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy.

RSK1 activation promotes invasion in nodular melanoma.

Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma.

Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma.

Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.

Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.

The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.

Pathways for Modulating Exosome Lipids Identified By High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1.

De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.

Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.

Genetic markers of pigmentation are novel risk loci for uveal melanoma.

Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care.

A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis.

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche.

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors.

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis.

Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.

Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples.

Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.

Impact of initial stage on metastatic melanoma survival.

Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM).

The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients.

Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.

Functional analysis of RPS27 mutations and expression in melanoma.

Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.

TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors.

The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.

Preliminary analysis of distinct clinical and biologic features of bone metastases in melanoma.

Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors.

Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma.

Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer.

Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients.

Tumor immunogenomic signatures improve a prognostic model of melanoma survival.

Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.

The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020.

Correction to: The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.

Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity.

Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma.

Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated Melanomas.

The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis.